Dear ASCO Member Letter From Klausner Attempts To Rescue Flagging BMT Trial.
McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.
ASCO Foundation Raised $200,000 In Its First Year.
ASCO Selects Three Cities For Quality Of Care Study.
Early Detection Network Completes Initial Funding From NCI.
FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.
Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.
One Health Plan, Genzyme Agree On Genetic Testing.
ECOG To Cease Participation In Melanoma Vaccine Study.
Vysis, Genentech In Agreement On HER-2 Breast Cancer Test.
Myriad Wins Patent For p10 Tumor Suppressor Gene.
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - Peter F. Garrett to people with cancer: Your story has power
- Lessons from the AIDS Quilt: what the cancer world can learn from AIDS advocacy
- Survivorship begins at diagnosis—cancer care system must recognize this
- House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget
